JPS58170718A - 抗眞菌作用を有する薬剤 - Google Patents
抗眞菌作用を有する薬剤Info
- Publication number
- JPS58170718A JPS58170718A JP57051165A JP5116582A JPS58170718A JP S58170718 A JPS58170718 A JP S58170718A JP 57051165 A JP57051165 A JP 57051165A JP 5116582 A JP5116582 A JP 5116582A JP S58170718 A JPS58170718 A JP S58170718A
- Authority
- JP
- Japan
- Prior art keywords
- selachii
- drug
- boiling point
- iodine value
- effects
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title abstract description 6
- 229940079593 drug Drugs 0.000 title abstract description 4
- 230000001857 anti-mycotic effect Effects 0.000 title 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229910052740 iodine Inorganic materials 0.000 claims abstract description 7
- 239000011630 iodine Substances 0.000 claims abstract description 7
- 238000009835 boiling Methods 0.000 claims abstract description 5
- 230000000694 effects Effects 0.000 abstract description 15
- 210000004185 liver Anatomy 0.000 abstract description 4
- 239000003242 anti bacterial agent Substances 0.000 abstract description 3
- 229940088710 antibiotic agent Drugs 0.000 abstract description 3
- 201000010099 disease Diseases 0.000 abstract description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 3
- 239000000284 extract Substances 0.000 abstract description 3
- 231100000053 low toxicity Toxicity 0.000 abstract description 3
- 239000002253 acid Substances 0.000 abstract description 2
- 241000252858 Selachii Species 0.000 abstract 3
- 241001303079 Galeus Species 0.000 abstract 1
- 241000251135 Scyliorhinidae Species 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 238000004458 analytical method Methods 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 229940040511 liver extract Drugs 0.000 abstract 1
- 244000005700 microbiome Species 0.000 abstract 1
- 239000000126 substance Substances 0.000 description 15
- 241000251730 Chondrichthyes Species 0.000 description 10
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 8
- APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 description 5
- 229960003942 amphotericin b Drugs 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 210000005253 yeast cell Anatomy 0.000 description 4
- 229930183010 Amphotericin Natural products 0.000 description 3
- QGGFZZLFKABGNL-UHFFFAOYSA-N Amphotericin A Natural products OC1C(N)C(O)C(C)OC1OC1C=CC=CC=CC=CCCC=CC=CC(C)C(O)C(C)C(C)OC(=O)CC(O)CC(O)CCC(O)C(O)CC(O)CC(O)(CC(O)C2C(O)=O)OC2C1 QGGFZZLFKABGNL-UHFFFAOYSA-N 0.000 description 3
- 229940009444 amphotericin Drugs 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 2
- 229940121375 antifungal agent Drugs 0.000 description 2
- 239000003429 antifungal agent Substances 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000022534 cell killing Effects 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 231100000956 nontoxicity Toxicity 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 229940031439 squalene Drugs 0.000 description 2
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 241001519451 Abramis brama Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 208000035943 Aphagia Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000251191 Callorhinchus milii Species 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 206010007134 Candida infections Diseases 0.000 description 1
- 241001416185 Carcharias Species 0.000 description 1
- 206010009152 Chronic tonsillitis Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 208000001388 Opportunistic Infections Diseases 0.000 description 1
- 241000063154 Parmaturus Species 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 201000003984 candidiasis Diseases 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57051165A JPS58170718A (ja) | 1982-03-31 | 1982-03-31 | 抗眞菌作用を有する薬剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57051165A JPS58170718A (ja) | 1982-03-31 | 1982-03-31 | 抗眞菌作用を有する薬剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS58170718A true JPS58170718A (ja) | 1983-10-07 |
| JPH0158167B2 JPH0158167B2 (enExample) | 1989-12-11 |
Family
ID=12879205
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP57051165A Granted JPS58170718A (ja) | 1982-03-31 | 1982-03-31 | 抗眞菌作用を有する薬剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS58170718A (enExample) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5470574A (en) * | 1986-08-21 | 1995-11-28 | J. W. Broadbent Nominees Pty. Ltd. | Active principle isolated from shark tissue |
| US6110472A (en) * | 1992-12-10 | 2000-08-29 | Hemogen Inc. | Vitamin B12 containing scalp and skin treatment compositions |
-
1982
- 1982-03-31 JP JP57051165A patent/JPS58170718A/ja active Granted
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5470574A (en) * | 1986-08-21 | 1995-11-28 | J. W. Broadbent Nominees Pty. Ltd. | Active principle isolated from shark tissue |
| US5632997A (en) * | 1986-08-21 | 1997-05-27 | J. W. Broadbent Nominees Pty. Ltd. | Method of treating liver disfunction in mammals, using active principle isolated from shark tissue |
| US6110472A (en) * | 1992-12-10 | 2000-08-29 | Hemogen Inc. | Vitamin B12 containing scalp and skin treatment compositions |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0158167B2 (enExample) | 1989-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Siheri et al. | The chemical and biological properties of propolis | |
| Padwad et al. | Effect of leaf extract of Seabuckthorn on lipopolysaccharide induced inflammatory response in murine macrophages | |
| US6063381A (en) | Therapeutic uses of pungent botanicals and their related compounds | |
| Harrison et al. | An assessment of the evidence for antibacterial activity of stinging nettle (Urtica dioica) extracts | |
| Vennila et al. | Efficacy of 10% whole Azadirachta indica (neem) chip as an adjunct to scaling and root planning in chronic periodontitis: A clinical and microbiological study | |
| JP4700808B2 (ja) | フルボ酸、および種々の状態の処置におけるその使用 | |
| Mikaeili et al. | Antifungal activities of Astragalus verus Olivier. against Trichophyton verrucosum on in vitro and in vivo guinea pig model of dermatophytosis | |
| Rahmani et al. | Effect of 0.5% Chitosan mouthwash on recurrent aphthous stomatitis: A randomized double-blind crossover clinical trial | |
| CN107847426A (zh) | 抗病毒组合物 | |
| Laila et al. | Wound healing effect of Haruan (Channa striatus) spray | |
| Lisnanti et al. | Antibacterial alternatives using the potential of the ant nest plant (Myrmecodia spp.) | |
| Amin | Biological assessment of ozone therapy on experimental oral candidiasis in immunosuppressed rats | |
| Silva et al. | A clinical trial to assess the use of sodium hypochlorite and oxytetracycline on the healing of digital dermatitis lesions in cattle | |
| CA2136174A1 (en) | Therapeutic uses of pungent botanicals and their related compounds | |
| CN111803624A (zh) | 一种含有转移因子的皮肤抗菌凝胶制剂和制备方法 | |
| WO2001026471A1 (en) | Pediculocidal and veterinary compositions | |
| Khan et al. | Combined effects of Aloe vera leaf extract and vitamin E on wound healing in Oryctolagus cuniculus (Rabbits) | |
| JPS5832818A (ja) | 爪の真菌感染の治療剤 | |
| US20190117559A1 (en) | Method of treating inflammation and promoting wound healing | |
| Barku et al. | In-vitro antioxidant and wound healing properties of Combretum dolichopetalum Engl. & Diels (Combretaceae) | |
| Aniya et al. | The effect of otic vehicle and concentration of dexamethasone on liver enzyme activities and adrenal function in small breed healthy dogs | |
| CN112236163B (zh) | 使用协同量的硼酸增强缩酚酸肽抗生素的抗菌作用 | |
| SU917839A1 (ru) | Способ лечени псориаза | |
| JP2004099613A (ja) | 自己免疫疾患治療用ガノデルマルシダム胞子 | |
| CN116602998B (zh) | 香榧籽油用于制备改善认知和/或神经保护药物的应用 |